跳至主要内容
临床试验/NCT04184583
NCT04184583尚未招募不适用

Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome

Beijing Anzhen Hospital1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2019年12月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
10,000
试验地点
1
主要终点
main adverse cardiovascular and cerebrovascular events (MACCE)

研究概览

简要总结

Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent has been signed.
  • Patients diagnosed in our hospital with acute coronary syndrome.
  • Life expectancy ≥12 months.

排除标准

  • Severe lack of important information such as history of previous medication, history of previous disease, history of surgery.
  • Pregnant and lactating women.
  • Mental disorders, or inability to communicate effectively with researchers, or failure to comply with research protocols.

结局指标

主要结局

main adverse cardiovascular and cerebrovascular events (MACCE)

时间窗: up to 5 years

MACCE will be defined as all-cause death, non-fatal stroke, non-fatal myocardial infarction (MI), and ischemic-driven revascularization.

次要结局

  • Adverse drug reaction(up to 5 years)

研究者

发起方
Beijing Anzhen Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lin Yang

Director of pharmacy department of Beijing Anzhen Hospital

Beijing Anzhen Hospital

研究点 (1)

Loading locations...

相似试验